Synthetic Biologics Inc
Change company Symbol lookup
Select an option...
SYN Synthetic Biologics Inc
XIN Xinyuan Real Estate Co Ltd
DMPI DelMar Pharmaceuticals Inc
FLR Fluor Corp
SPLK Splunk Inc
LB L Brands Inc
TEAM Atlassian Corporation PLC
GRAS Greenfield Farms Food Inc
CMS CMS Energy Corp
BAC Bank of America Corp
Go

Health Care : Biotechnology | Small Cap GrowthCompany profile

Synthetic Biologics, Inc. is a clinical-stage company. The Company is engaged in developing therapeutics to protect the gut microbiome while targeting pathogen-specific diseases. The Company's lead product candidates in Phase II development are SYN-010, which is intended to reduce the impact of methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C), and SYN-004, which is designed to protect the gut microbiome (gastrointestinal (GI) microflora) from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection (CDI) and antibiotic-associated diarrhea (AAD). Its other product candidates include SYN-007, SYN-006, SYN-005, SYN-200 and SYN-020. The Company is also developing preclinical-stage monoclonal antibody therapies for the prevention and treatment of pertussis, and discovery-stage biotherapeutics for the treatment of phenylketonuria (PKU).

Price
Delayed
$0.5448
Day's Change
-0.0152 (-2.71%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.5629
Day's Low
0.54
Volume
(Heavy Day)

Today's volume of 85,865 shares is on pace to be much greater than SYN's 10-day average volume of 69,970 shares.

85,865
  • Prev Close
    0.56
  • Today's Open
    0.5603
  • Day's Range
    0.54-0.5629
  • Avg Vol (10-day)
    70.0K
  • Last (time)
    1:18p ET 05/23/19
  • Last (size)
    30
  • 52-Wk Range
    0.508 - 9.38
    LowHigh
  • (05/23/18 - 12/27/18)
    7.24%
  • 97.3%
  • Market Cap
    9.0M
  • Shares Outstanding
    16.5M
  • -3.44
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 2.4
  • 12.60
  • (% of float 04/30/19)
    1.25

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.